Clifford Chance advised Mao Geping Cosmetics, while Paul Hastings advised the underwriters on the deal. Mao Geping Cosmetics completed its initial public offering and listing on...
Mao Geping Cosmetics’ $300 Million IPO On HKSE
S.F. Holding’s $750 Million IPO On HKSE
Herbert Smith Freehills advised SF Holding on the deal, while Clifford Chance advised the underwriters. S.F. Holding Co., Ltd. completed its global offering and listing on...
Mobvoi Inc.’s IPO on Hong Kong Stock Exchange
Clifford Chance has advised the joint sponsors CICC and CMBI on the deal. Mobvoi Inc. has completed the initial public offering and listing on the Main Board...
BNP Paribas Cardif’s Acquisition of Fosun’s Stake In Ageas
Clifford Chance advises Fosun on the sale. BNP Paribas Cardif, the insurance subsidiary of French financial services giant BNP Paribas, has entered into an agreement to...
Stellantis’ €1.5 Billion Investment in Zhejiang Leapmotor Technology Co., Ltd.
Clifford Chance has advised Zhejiang Leapmotor Technology Co., Ltd. on the deal. Stellantis N.V. plans to invest ca. €1.5 billion to acquire approximately 20% of Leapmotor, making...
Sunshine Insurance’s HK$6.7 Billion IPO
Linklaters and King & Wood Mallesons advised the joint sponsors and underwriters in connection with the offering. Clifford Chance advised Beijing-based Sunshine Insurance Group. China’s Sunshine...
CALB Co., Ltd.’s US$1.3 Billion Global Initial Public Offering
Clifford Chance has advised sponsor Huatai Securities Company Limited on the deal. Stevenson, Wong & Co. acted for Jiangmen City Haina New Energy Investment Partnership. CALB...
Leapmotor Technology Co., Ltd.’s US$807 Million Hong Kong IPO and Listing
Clifford Chance has advised Chinese EV maker Zhejiang Leapmotor Technology Co., Ltd. on the deal. Simpson Thacher represented the underwriters in the initial public offering. Leapmotor...
Tianqi Lithium’s Initial Public Offering
Zhong Lun, Latham & Watkins and Clayton Utz advised Tianqi Lithium on the offering. Clifford Chance advised the joint sponsors and the joint global coordinators. Tianqi...
Lepu Biopharma’s US$116.1 Million Hong Kong IPO and Listing
Clifford Chance has advised Lepu Biopharma Co., Ltd. on the deal. Herbert Smith Freehills has advised CICC and Morgan Stanley. The Joint Sponsors are CICC and...
Qingdao AInnovation Technology’s Initial Public Offering
Clifford Chance has advised Qingdao AInnovation Technology Group Co. Ltd. Qingdao AInnovation Technology Group Co. Ltd. raised US$151 million in its initial public offering (IPO) and...
Hangzhou SF Intra-city Industrial Co., Ld.’s Mainboard Listing on the Hong Kong Stock Exchange
Herbert Smith Freehills advised the joint sponsors involved in the IPO. Clifford Chance advised SF Intra-City Industrial Co. Ltd. SF Intra-city operates China’s largest third-party on-demand...